Type Here to Get Search Results !

News 365 for everyone

Ahmedabad-based Nirma is set to acquire Glenmark Life Sciences (GLS), a subsidiary of Glenmark Pharma, for Rs 5,652 crore. This move marks Nirma's entry into the active pharmaceutical ingredient (API) sector and expands its pharmaceutical portfolio, which includes injectables, parentals, and ophthalmic products. GLS specializes in developing APIs for various therapeutic segments.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/vwb20NR
via IFTTT

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.